October 5, 2007 - Shanghai Ossur, a leading provider of non-invasive orthopaedic products and services, today announced the inauguration of its Asia Pacific operations in Shanghai, China. Ossur, renowned for its pioneering work in lower-limb prosthetics and a comprehensive range of braces and supports, established its China office as the regional headquarters catering to customers not just in China but across Asia including Japan, South Korea and Australia.
The total prosthetic market in Asia is USD260 million of which USD56 million is in components and devices. In China, we estimate the total market being USD35 million. In Asia, lifestyle diseases such as diabetes and other arterial diseases that lead to amputation are showing a significant rise as compared to Western countries. In addition, workplace accidents or trauma have also led to increased lower-limb amputations. There are approximately 2.2 million amputees in China with over 100,000 new amputees expected each year . It is estimated that 70% of amputations are related to some form of trauma .
China will become the third largest healthcare market by the year 2020, said Arni Alvar Arason, president Ossur Asia. China has all the key elements that make it the ideal choice for our regional headquarters investment, distribution, supply chain network, proximity to key Asian markets - not to mention a growing patient base requiring prosthetics. Ossur is already looking into setting up manufacturing and R&D capabilities in the very near future. Currently, Ossur provides prosthetics and components to about 15,000 Chinese patients who use them on a daily basis. When Ossur begins to supply and distribute braces and supports from its Asia office, this category is expected to grow significantly.
Establishing an office in China to meet market demand in this region is part of Ossurs 2010 company vision: to focus more on Asian markets. Presiding at the inauguration, president & CEO Jon S
|Contact: Edda Geirsdottir|